Kagenmi / iStockphoto.com
Danish biotechnology company Novozymes has won a patent dispute against China-based enzyme makers Shandong Longda Bio-Products and Jiangsu Boli Bioproducts at theSupreme People’s Court of China.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Novozymes, enzymes, patent, patent infringement, Supreme People’s Court of China, Shandong Longda Bio-Products, Jiangsu Boli Bioproducts, China